PL3319586T3 - Formulacja farmaceutyczna do leczenia zmian zapalnych odbytnicy - Google Patents

Formulacja farmaceutyczna do leczenia zmian zapalnych odbytnicy

Info

Publication number
PL3319586T3
PL3319586T3 PL16732617.2T PL16732617T PL3319586T3 PL 3319586 T3 PL3319586 T3 PL 3319586T3 PL 16732617 T PL16732617 T PL 16732617T PL 3319586 T3 PL3319586 T3 PL 3319586T3
Authority
PL
Poland
Prior art keywords
rectum
treatment
pharmaceutical preparations
inflammatory conditions
inflammatory
Prior art date
Application number
PL16732617.2T
Other languages
English (en)
Inventor
Rudolph WILHELM
Markus PRÖLS
Roland Greinwald
Ralf Mohrbacher
Original Assignee
Dr. Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Falk Pharma Gmbh filed Critical Dr. Falk Pharma Gmbh
Publication of PL3319586T3 publication Critical patent/PL3319586T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL16732617.2T 2015-07-08 2016-06-28 Formulacja farmaceutyczna do leczenia zmian zapalnych odbytnicy PL3319586T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15175806.7A EP3115037B1 (de) 2015-07-08 2015-07-08 Pharmazeutische formulierung zur behandlung von entzündlichen veränderungen des enddarms
PCT/EP2016/064907 WO2017005524A1 (de) 2015-07-08 2016-06-28 Pharmazeutische formulierung zur behandlung von entzündlichen veränderungen des enddarms

Publications (1)

Publication Number Publication Date
PL3319586T3 true PL3319586T3 (pl) 2023-05-08

Family

ID=53540667

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16732617.2T PL3319586T3 (pl) 2015-07-08 2016-06-28 Formulacja farmaceutyczna do leczenia zmian zapalnych odbytnicy

Country Status (23)

Country Link
US (4) US10905699B2 (pl)
EP (2) EP3115037B1 (pl)
JP (1) JP6857644B2 (pl)
CN (1) CN107847435B (pl)
AU (1) AU2016290343B2 (pl)
CA (1) CA2986081C (pl)
DK (1) DK3319586T3 (pl)
EA (1) EA033153B1 (pl)
ES (2) ES2688119T3 (pl)
FI (1) FI3319586T3 (pl)
HR (1) HRP20230174T1 (pl)
HU (1) HUE061585T2 (pl)
IL (1) IL255247B (pl)
LT (1) LT3319586T (pl)
MA (1) MA42367B1 (pl)
MD (1) MD3319586T2 (pl)
PL (1) PL3319586T3 (pl)
PT (2) PT3115037T (pl)
RS (1) RS64020B1 (pl)
SI (1) SI3319586T1 (pl)
UA (1) UA120075C2 (pl)
WO (1) WO2017005524A1 (pl)
ZA (1) ZA201707777B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115529815B (zh) * 2021-04-27 2024-04-30 广州共禾医药科技有限公司 经直肠施用的奥司他韦或其药学上可接受的盐的药物组合物、及其制备方法和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB701831A (en) * 1950-10-19 1954-01-06 Rudolf Von Wuelfing Process for the production of suppositories containing medicaments
US3208907A (en) * 1961-11-13 1965-09-28 Lab Toraude Stabilized salicylate compositions
DE3709861A1 (de) * 1987-03-25 1988-10-06 Henkel Kgaa Emulgierende suppositoriengrundmassen und daraus hergestellte zaepfchen
JP2927830B2 (ja) * 1989-09-01 1999-07-28 東京田辺製薬株式会社 ダナゾール坐剤
IT1243379B (it) 1990-07-27 1994-06-10 Giuliani Spa Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
DE29717252U1 (de) 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
DE19849737A1 (de) * 1998-10-28 2000-05-04 Falk Pharma Gmbh Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen
US20020085978A1 (en) * 2000-11-10 2002-07-04 Mina Buenafe Degradation-resistant glucocorticosteroid formulations
CU23203A1 (es) * 2002-12-27 2007-05-18 Ct Ingenieria Genetica Biotech Formulaciones que contienen agentes de accion trombolitica para su administracion por via rectal
US8476233B2 (en) * 2003-08-29 2013-07-02 Therapeutic Research, Llc Methods for treatment for ulcerative colitis in mammals
JP5223307B2 (ja) * 2006-11-17 2013-06-26 大正製薬株式会社 坐剤
JP2012509892A (ja) * 2008-11-26 2012-04-26 サティオゲン ファーマシューティカルズ，インク． サティオゲン類を含有する組成物及び使用の方法
WO2012022796A2 (de) * 2010-08-20 2012-02-23 Boehringer Ingelheim International Gmbh Neue kombinationen
CN102525883B (zh) * 2010-12-09 2013-05-08 丽珠集团丽珠制药厂 一种伏立康唑栓剂及其制备方法和用途
WO2015073846A1 (en) 2013-11-15 2015-05-21 Salix Pharmaceuticals, Inc. Method of treating ulcerative colitis

Also Published As

Publication number Publication date
CA2986081C (en) 2024-02-20
EP3115037A1 (de) 2017-01-11
LT3319586T (lt) 2023-03-10
ES2688119T3 (es) 2018-10-31
NZ736749A (en) 2023-12-22
JP6857644B2 (ja) 2021-04-14
EP3319586B1 (de) 2023-01-18
ZA201707777B (en) 2018-11-28
AU2016290343B2 (en) 2020-10-15
JP2018519345A (ja) 2018-07-19
DK3319586T3 (da) 2023-02-27
EA201792685A1 (ru) 2018-07-31
US20260053818A1 (en) 2026-02-26
CA2986081A1 (en) 2017-01-12
MA42367A (fr) 2018-05-16
IL255247B (en) 2020-11-30
EA033153B1 (ru) 2019-09-30
US11738032B2 (en) 2023-08-29
PT3115037T (pt) 2018-10-22
IL255247A0 (en) 2017-12-31
EP3115037B1 (de) 2018-08-15
HRP20230174T1 (hr) 2023-04-14
WO2017005524A1 (de) 2017-01-12
CN107847435B (zh) 2021-07-27
SI3319586T1 (sl) 2023-03-31
EP3319586A1 (de) 2018-05-16
PT3319586T (pt) 2023-02-14
FI3319586T3 (fi) 2023-03-22
HUE061585T2 (hu) 2023-07-28
ES2938358T3 (es) 2023-04-10
UA120075C2 (uk) 2019-09-25
RS64020B1 (sr) 2023-03-31
US12472191B2 (en) 2025-11-18
US20230364113A1 (en) 2023-11-16
US20210100819A1 (en) 2021-04-08
AU2016290343A1 (en) 2017-11-16
US20180200268A1 (en) 2018-07-19
CN107847435A (zh) 2018-03-27
MA42367B1 (fr) 2023-02-28
US10905699B2 (en) 2021-02-02
MD3319586T2 (ro) 2023-04-30

Similar Documents

Publication Publication Date Title
ZA201806819B (en) Pharmaceutical combinations for the treatment of cancer
HUE053115T2 (hu) Topikális gyógyszerészeti formulációk gyulladással összefüggõ állapotok kezelésére
HUE053309T2 (hu) Új sók és gyógyászati készítmények gyulladásos betegségek kezelésére
PT3169328T (pt) Derivados de quinolina para o tratamento de doenças inflamatórias
IL259281B (en) History of bipyrazolyl used in the treatment of autoimmune diseases
HUE059694T2 (hu) Készítmény rák kezelésére
LT3473263T (lt) Kombinuoti preparatai, skirti vėžio gydymui
EP3148532A4 (en) Pharmaceutical combination for the treatment of cancer
GB201402070D0 (en) Pharmaceutical compositions for the treatment of inflammatory disorders
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL246823A0 (en) History of benzimidazole and their pharmaceutical preparations for the treatment of inflammatory disorders
IL248779A0 (en) Pharmaceutical compositions for treating infectious diseases
GB201518456D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory, autoimmune and/or proliferative diseases
IL252774A0 (en) A pharmaceutical preparation for the treatment of fungus
PL3319586T3 (pl) Formulacja farmaceutyczna do leczenia zmian zapalnych odbytnicy
KR101583452B9 (ko) 위장질환 치료용 의약 조성물
IL257689B (en) Pharmaceutical preparations and methods for treating diseases related to lack of oxygen
PL3164110T3 (pl) Kompozycje farmaceutyczne do leczenia łuszczycy
SG10201913141UA (en) Treatment of alphavirus-induced inflammation
AU2015902358A0 (en) Treatment of inflammatory disease
HK1236134A1 (en) Pharmaceutical combination for the treatment of cancer